1 |
Sulfated polysaccharides |
Brawn algae |
Human leukemic monocyte lymphoma cell line (U-937) |
Inhibition of cell proliferation |
[1] |
2 |
Polysaccharides |
Capsosiphon fulvescens
|
Gastric cancer cells |
Modulation of PI3K/Akt pathway |
[96] |
3 |
Polysaccharides |
U. lactuca
|
DMBA-induced breast cancer model |
Diminished lipid peroxidation also GPx activity |
[97] |
4 |
Polysaccharides |
Champia feldmannii
|
Mice transplanted with sarcoma 180 tumors |
Reduction of tumor growth |
[98] |
5 |
Polysaccharides |
U. lactuca
|
DMBA-induced breast cancer in rat |
Prevented breast-histological alterations and carcinogenic wounds |
[97] |
6 |
Polysaccharides |
U. lactuca
|
Breast cancer cells |
p53 expression and inhibited the Bcl-2 expression |
[97] |
7 |
Fucoidan |
Costaria costata
|
DLD-1 |
55% (100 μg/mL) |
[107] |
SK-MEL-28 |
20% (100 μg/mL) |
[107] |
8 |
Fucoidans |
U. pinnatifida
|
DU-145 cell-induced xenograft rat model |
Inhibition of the JAK3/STAT pathway |
[99] |
9 |
Fucoidan |
Fucus vesiculosus
|
HCT116 human colorectal carcinoma cell line |
p53-independent |
[74] |
10 |
Fucoidan |
L. japonica
|
HT-29 cell line |
Caspase-3, PARP, and DNA degradation |
[100] |
11 |
Fucoidan |
E. cava
|
MDA-MB231 and MCF-7 cells |
Induction of p53 and activation of Bax, caspases 3 and 9, and PARP with inhibition of Bcl-2 |
[76] |
12 |
Fucoidan |
Cladosiphon okamuranus
|
MCF-7 cells |
Activation of caspase-3 and DNA fragmentation |
[101] |
13 |
Extracts |
F. vesiculosus
|
Human colon cancer cells |
Cytoplasmic release of cytochrome C and the Smac/DIABLO pathway |
[102] |
14 |
Fucoidan |
F. vesiculosus
|
HT-29 colon cancer cells |
Decreased expression of Bcl-xL, Bcl-2 and upregulation of Bax, pro-caspases 3, 7, and 9 |
[103] |
15 |
Fucoidan |
F. vesiculosus
|
HT-29 colon cancer cells |
Upregulation of Rb and E2 factor proteins and Fas regulation |
[103] |
16 |
Fucoxanthin |
Laminaria japonica
|
Human colon adenocarcinoma WiDr cells |
DNA fragmentation |
[91] |
17 |
Fucoxanthin |
Ishige okamurae
|
Melanoma B16F10 cells |
Caspases activation and reduction of BclxL and IAP expression |
[90] |
18 |
Dieckol |
E. cava
|
Albino rats |
Decreased cancer cell proliferation |
[95] |
19 |
Guaiane sesquiterpene |
Ulva fasciata
|
MDA MB-231 breast cancer cell line |
Direct interaction with kinase site of EGFR |
[82] |
20 |
Halogenated monoterpene, mertensene |
Pterocladiella capillacea
|
HT-29 and LS174 |
ERK1/2, Akt, and NF B pathways |
[78] |
21 |
Ethanolic and methanolic extracts |
Gracilaria tenuistipitata
|
Ca9-22 oral cancer cells |
DNA damage |
[88] |
22 |
Methanolic extract |
Plocamium telfairiae
|
HT-29 colon cancer cells |
Induced caspase-dependent |
[88] |
23 |
Iodine and polyphenols |
L. japonica
|
HT-29 colon cancer cells |
Inhibition of SOD activity |
[105] |
24 |
Extract |
Eucheuma cottonii
|
Cancer-induced rats |
Upregulation of antioxidant enzymes, e.g., CAT, SOD, and GPx |
[89] |
25 |
Methanolic extracts |
Fucus serratus and F. vesiculosus
|
Caco-2 cells |
DNA damage |
[106] |
26 |
Methanolic extracts |
Pelvetia canaliculata
|
Caco-2 cells |
Inhibited H2O2-induced SOD depletion |
[106] |
27 |
Ethanol extracts |
C. japonica
|
Caco-2 cells |
Activating cellular antioxidant enzymes |
[63] |
28 |
Aqueous extract |
G. tenuistipitata
|
H1299 cell line |
Activating cellular antioxidant enzymes |
[59] |